Journal article
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
- Abstract:
-
BACKGROUND: The efficacy of bacille Calmette-Guérin (BCG) may be enhanced by heterologous vaccination strategies that boost the BCG-primed immune response. One leading booster vaccine, MVA85A (where "MVA" denotes "modified vaccinia virus Ankara"), has shown promising safety and immunogenicity in human trials performed in the United Kingdom. We investigated the safety and immunogenicity of MVA85A in mycobacteria-exposed--but Mycobacterium tuberculosis-uninfected--healthy adults from a region ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Journal of infectious diseases
- Volume:
- 198
- Issue:
- 4
- Pages:
- 544-552
- Publication date:
- 2008-08-01
- DOI:
- EISSN:
-
1537-6613
- ISSN:
-
0022-1899
- Source identifiers:
-
40815
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:40815
- UUID:
-
uuid:9394e83f-bc56-424e-8f14-6fa737c5ee81
- Local pid:
- pubs:40815
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2008
If you are the owner of this record, you can report an update to it here: Report update to this record